SCHEMBL15909580

SCHEMBL15909580

Brc1ccc(-c2noc(C3CC3)n2)cc1.CCN(CC)CC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.68
NPC1 O15118 3/20 0.68
L3MBTL1 Q9Y468 2/20 0.68
MAOA P21397 1/20 0.52
MAOB P27338 1/20 0.52
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA9 Q16790 1/20 0.51
LMNA P02545 2/20 0.50
HTT P42858 2/20 0.50
GAA P10253 3/20 0.49
MAPT P10636 1/20 0.49
KDM4E B2RXH2 1/20 0.49
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
AOC3 Q16853 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12478358 0.89 RAB9A (0.85) RAB9ANPC1L3MBTL1MAOAMAOB
SCHEMBL14061846 0.83 NPC1 (0.97) RAB9ANPC1L3MBTL1MAOAMAOB
SCHEMBL4419275 0.79 NPC1 (0.74) RAB9ANPC1L3MBTL1MAOAMAOB
SCHEMBL6468865 0.79 RAB9A (0.60) RAB9ANPC1L3MBTL1MAOAMAOB
SCHEMBL31375520 0.79 RAB9A (0.60) RAB9ANPC1L3MBTL1MAOAMAOB
SCHEMBL12188551 0.76 NPC1 (0.85) RAB9ANPC1L3MBTL1MAOAMAOB
SCHEMBL27035104 0.74 SIRT2 (0.60) RAB9ANPC1L3MBTL1LMNAHTT
SCHEMBL13416897 0.74 GAA (0.73) RAB9ANPC1L3MBTL1MAOAMAOB
SCHEMBL25338113 0.73 CA12 (0.66) RAB9ANPC1L3MBTL1MAOAMAOB
SCHEMBL21889825 0.73 CA12 (0.61) RAB9ANPC1L3MBTL1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3243385-B1 NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS MERCK SHARP & DOHME (US) 2021-01-13 EP disclosed
EP-3243385-A1 NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS Merck Sharp & Dohme Corp. (US) 2017-11-15 EP disclosed
EP-2677869-B1 NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS MERCK SHARP & DOHME (US) 2017-11-08 EP disclosed
US-8796258-B2 Cyclic azabenzimidazole derivatives useful as anti-diabetic agents MERCK SHARP & DOHME CORP. (US) 2014-08-05 US disclosed